Convergence of mRNA technology and chimeric antigen receptor therapy: targeted technology optimizing targeted therapy

Huajing Chen; Jiayi Zhang; Jiansong Huang; Zichen Wu; Lirui Tang; Yuxin Tian; Shan Gao; Shihan Huang; Jiaying Cao; Jiali Chen; Yuhua Li

doi:10.1186/s12967-025-07470-7

Affiliated Institutions

Related Publications

Chimeric Antigen Receptor Therapy

Carl H. June , Michel Sadelain

Interview with Dr. Carl June on chimeric antigen receptor therapy. (09:04)Download This review addresses T-cell engineering and synthetic immunity, with a focus on producing dur...

2018 New England Journal of Medicine 2080 citations

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

Stephan A. Grupp , Michael Kalos , David M. Barrett +10 more

Chimeric antigen receptor-modified T cells with specificity for CD19 have shown promise in the treatment of chronic lymphocytic leukemia (CLL). It remains to be established whet...

2013 New England Journal of Medicine 3403 citations

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Jesús G. Berdeja , Deepu Madduri , Saad Z. Usmani +33 more

CARTITUDE-1 aimed to assess the safety and clinical activity of ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor T-cell therapy with two B-cell maturation anti...

2021 The Lancet 1466 citations

CAR-T cell therapy: current limitations and potential strategies

Robert C. Sterner , Rosalie M. Sterner

Chimeric antigen receptor (CAR)-T cell therapy is a revolutionary new pillar in cancer treatment. Although treatment with CAR-T cells has produced remarkable clinical responses ...

2021 Blood Cancer Journal 2373 citations

Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells

Zibing Wang , Brian G. Till , Quanli Gao

Immunotherapy has shown great promise in the fight against cancer, as evidenced by the clinical efficacy of chimeric antigen receptor T cells in hematologic malignancies and che...

2017 OncoImmunology 148 citations

Publication Info

Year: 2025
Type: article
Volume: 23
Issue: 1
Pages: 1393-1393
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Convergence of mRNA technology and chimeric antigen receptor therapy: targeted technology optimizing targeted therapy

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                
                                    Huajing Chen, 
                                
                                    Jiayi Zhang, 
                                
                                    Jiansong Huang
                                
                                et al.
                            
                            (2025). 
                            Convergence of mRNA technology and chimeric antigen receptor therapy: targeted technology optimizing targeted therapy. 
                            Journal of Translational Medicine
                            , 23
                            (1)
                            , 1393-1393.
                            https://doi.org/10.1186/s12967-025-07470-7
                        

Identifiers

DOI: 10.1186/s12967-025-07470-7